740 related articles for article (PubMed ID: 19276989)
1. C-reactive protein upregulates receptor for advanced glycation end products expression and alters antioxidant defenses in rat endothelial progenitor cells.
Chen J; Huang L; Song M; Yu S; Gao P; Jing J
J Cardiovasc Pharmacol; 2009 May; 53(5):359-67. PubMed ID: 19276989
[TBL] [Abstract][Full Text] [Related]
2. C-reactive protein alters antioxidant defenses and promotes apoptosis in endothelial progenitor cells.
Fujii H; Li SH; Szmitko PE; Fedak PW; Verma S
Arterioscler Thromb Vasc Biol; 2006 Nov; 26(11):2476-82. PubMed ID: 16931792
[TBL] [Abstract][Full Text] [Related]
3. C-reactive protein down-regulates endothelial nitric oxide synthase expression and promotes apoptosis in endothelial progenitor cells through receptor for advanced glycation end-products.
Chen J; Jin J; Song M; Dong H; Zhao G; Huang L
Gene; 2012 Apr; 496(2):128-35. PubMed ID: 22301267
[TBL] [Abstract][Full Text] [Related]
4. C-Reactive protein upregulates receptor for advanced glycation end products expression in human endothelial cells.
Zhong Y; Li SH; Liu SM; Szmitko PE; He XQ; Fedak PW; Verma S
Hypertension; 2006 Sep; 48(3):504-11. PubMed ID: 16847147
[TBL] [Abstract][Full Text] [Related]
5. Nifedipine inhibits gene expression of receptor for advanced glycation end products (RAGE) in endothelial cells by suppressing reactive oxygen species generation.
Yamagishi S; Takeuchi M
Drugs Exp Clin Res; 2004; 30(4):169-75. PubMed ID: 15553663
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of GSPE on RAGE expression induced by advanced glycation end products in endothelial cells.
Zhang FL; Gao HQ; Shen L
J Cardiovasc Pharmacol; 2007 Oct; 50(4):434-40. PubMed ID: 18049312
[TBL] [Abstract][Full Text] [Related]
7. C-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function: further evidence of a mechanistic link between C-reactive protein and cardiovascular disease.
Verma S; Kuliszewski MA; Li SH; Szmitko PE; Zucco L; Wang CH; Badiwala MV; Mickle DA; Weisel RD; Fedak PW; Stewart DJ; Kutryk MJ
Circulation; 2004 May; 109(17):2058-67. PubMed ID: 15078802
[TBL] [Abstract][Full Text] [Related]
8. C-reactive protein (CRP) up-regulates expression of receptor for advanced glycation end products (RAGE) and its inflammatory ligand EN-RAGE in THP-1 cells: inhibitory effects of atorvastatin.
Mahajan N; Bahl A; Dhawan V
Int J Cardiol; 2010 Jul; 142(3):273-8. PubMed ID: 19201044
[TBL] [Abstract][Full Text] [Related]
9. Advanced glycation end products depress function of endothelial progenitor cells via p38 and ERK 1/2 mitogen-activated protein kinase pathways.
Sun C; Liang C; Ren Y; Zhen Y; He Z; Wang H; Tan H; Pan X; Wu Z
Basic Res Cardiol; 2009 Jan; 104(1):42-9. PubMed ID: 18622638
[TBL] [Abstract][Full Text] [Related]
10. C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle.
Wang CH; Li SH; Weisel RD; Fedak PW; Dumont AS; Szmitko P; Li RK; Mickle DA; Verma S
Circulation; 2003 Apr; 107(13):1783-90. PubMed ID: 12665485
[TBL] [Abstract][Full Text] [Related]
11. Advanced glycation endproducts alter functions and promote apoptosis in endothelial progenitor cells through receptor for advanced glycation endproducts mediate overpression of cell oxidant stress.
Chen J; Song M; Yu S; Gao P; Yu Y; Wang H; Huang L
Mol Cell Biochem; 2010 Feb; 335(1-2):137-46. PubMed ID: 19756958
[TBL] [Abstract][Full Text] [Related]
12. Advanced glycation end products in diabetic patients with optimized glycaemic control and their effects on endothelial reactivity: possible implications in venous graft failure.
Chello M; Spadaccio C; Lusini M; Covino E; Blarzino C; De Marco F; Di Domenico F; Coccia R
Diabetes Metab Res Rev; 2009 Jul; 25(5):420-6. PubMed ID: 19405075
[TBL] [Abstract][Full Text] [Related]
13. Advanced glycation end products impair function of late endothelial progenitor cells through effects on protein kinase Akt and cyclooxygenase-2.
Chen Q; Dong L; Wang L; Kang L; Xu B
Biochem Biophys Res Commun; 2009 Apr; 381(2):192-7. PubMed ID: 19232321
[TBL] [Abstract][Full Text] [Related]
14. Advanced glycation endproducts increase EPC apoptosis and decrease nitric oxide release via MAPK pathways.
Shen C; Li Q; Zhang YC; Ma G; Feng Y; Zhu Q; Dai Q; Chen Z; Yao Y; Chen L; Jiang Y; Liu N
Biomed Pharmacother; 2010 Jan; 64(1):35-43. PubMed ID: 19766439
[TBL] [Abstract][Full Text] [Related]
15. Pigment-epithelium-derived factor suppresses expression of receptor for advanced glycation end products in the eye of diabetic rats.
Yamagishi S; Matsui T; Nakamura K; Yoshida T; Takeuchi M; Inoue H; Yoshida Y; Imaizumi T
Ophthalmic Res; 2007; 39(2):92-7. PubMed ID: 17284935
[TBL] [Abstract][Full Text] [Related]
16. Metformin inhibits advanced glycation end products (AGEs)-induced renal tubular cell injury by suppressing reactive oxygen species generation via reducing receptor for AGEs (RAGE) expression.
Ishibashi Y; Matsui T; Takeuchi M; Yamagishi S
Horm Metab Res; 2012 Nov; 44(12):891-5. PubMed ID: 22864903
[TBL] [Abstract][Full Text] [Related]
17. At least 2 distinct pathways generating reactive oxygen species mediate vascular cell adhesion molecule-1 induction by advanced glycation end products.
Basta G; Lazzerini G; Del Turco S; Ratto GM; Schmidt AM; De Caterina R
Arterioscler Thromb Vasc Biol; 2005 Jul; 25(7):1401-7. PubMed ID: 15845907
[TBL] [Abstract][Full Text] [Related]
18. Induction of apoptosis of Beta cells of the pancreas by advanced glycation end-products, important mediators of chronic complications of diabetes mellitus.
Lim M; Park L; Shin G; Hong H; Kang I; Park Y
Ann N Y Acad Sci; 2008 Dec; 1150():311-5. PubMed ID: 19120318
[TBL] [Abstract][Full Text] [Related]
19. Methylglyoxal induces oxidative stress-dependent cell injury and up-regulation of interleukin-1beta and nerve growth factor in cultured hippocampal neuronal cells.
Di Loreto S; Caracciolo V; Colafarina S; Sebastiani P; Gasbarri A; Amicarelli F
Brain Res; 2004 May; 1006(2):157-67. PubMed ID: 15051519
[TBL] [Abstract][Full Text] [Related]
20. Receptor of advanced glycation end products (RAGE) positively regulates CD36 expression and reactive oxygen species production in human monocytes in diabetes.
Xanthis A; Hatzitolios A; Fidani S; Befani C; Giannakoulas G; Koliakos G
Angiology; 2009 Dec-2010 Jan; 60(6):772-9. PubMed ID: 19190027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
